Search clinical trials for: Rituxumab
Total 2106 results
-
Michael DonahoeCompleted
-
Hospital Universitario Dr. Jose E. GonzalezWithdrawn
-
Fondazione Italiana Linfomi ONLUSUnknownDiffuse Large B-cell LymphomaItaly
-
Corixa CorporationUnknownNon-Hodgkin's LymphomaUnited States
-
Pakistan Institute of Medical SciencesWorld Health OrganizationCompletedPneumonia | Acute Respiratory InfectionsPakistan
-
PfizerWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid System NeoplasmUnited States
-
Kim, Seok JinCelltrion; Samyang Biopharmaceuticals CorporationRecruitingPrimary CNS LymphomaKorea, Republic of
-
Swiss Group for Clinical Cancer ResearchTerminatedLymphomaSwitzerland, Norway, Sweden
-
International Extranodal Lymphoma Study Group (IELSG)CompletedMarginal Zone B-cell LymphomaItaly, France
-
University of California, San DiegoBristol-Myers SquibbTerminatedChronic Lymphocytic LeukemiaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieCompletedLymphoma of the Mucosa Associated Lymphoid Tissue (MALT)Austria
-
Seoul National University HospitalChonbuk National University Hospital; Seoul National University Bundang Hospital and other collaboratorsCompletedMarginal Zone B-cell LymphomaKorea, Republic of
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicItaly
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
GlaxoSmithKlineCompletedLymphoma, Large-Cell, DiffuseUnited States, Netherlands, Estonia, Spain, United Kingdom, Sweden, Israel, Poland, Belgium, Korea, Republic of, Singapore, Austria, Germany, Finland, Ireland, Thailand, China, Russian Federation, Czech Republic, Argentina, Denmark and more
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Australia, Canada
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
CTI BioPharmaWithdrawnNon-Hodgkin's LymphomaUnited States
-
PfizerUCB PharmaTerminatedLymphoma, Non-HodgkinCanada, United States, Spain, France, Singapore, Taiwan, Japan, Ireland, Belgium, United Kingdom, Germany, Slovakia, Thailand, Croatia, Czechia, Russian Federation, India, Sweden, Poland, Bulgaria, Hungary, Lithuania, Mexico, Puerto Rico and more
-
University of FloridaWithdrawnCleft PalateUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent T-Cell Non-Hodgkin LymphomaUnited States
-
EnteromeRecruitingFollicular Lymphoma | Marginal Zone LymphomaUnited States, Italy, Spain
-
Assistance Publique - Hôpitaux de ParisFrench Vasculitis Study GroupActive, not recruitingEosinophilic Granulomatosis With PolyangiitisFrance
-
First Affiliated Hospital, Sun Yat-Sen UniversitySecond Affiliated Hospital of Guangzhou Medical UniversityUnknown
-
AZ-VUBUnknownDiabetes Mellitus, Type 1Belgium
-
Grupo Oncológico para el Tratamiento y el Estudio...UnknownFollicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line.Spain
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent Burkitt Lymphoma | AIDS-Related Burkitt Lymphoma | Atypical Burkitt/Burkitt-Like Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2... and other conditionsUnited States
-
University of RochesterWithdrawnActive Chronic Graft Versus Host DiseaseUnited States
-
Scripps HealthRecruiting
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
PharmatechCephalonCompletedDiffuse Large B-Cell LymphomaUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); BiogenCompletedLymphomaUnited States
-
National Cancer Institute (NCI)TerminatedB-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
University of NebraskaSchering-PloughCompletedNon-Hodgkins LymphomaUnited States
-
University of GöttingenRoche Pharma AG; Mundipharma Research GmbH & Co KGCompleted
-
PfizerUCB PharmaCompletedLymphoma, B-CellUnited States, France, United Kingdom, Singapore, Korea, Republic of, Germany
-
Astellas Pharma Europe B.V.CompletedChronic Lymphocytic LeukemiaRussian Federation
-
Astellas Pharma Europe B.V.CompletedLymphoma, Non-HodgkinRussian Federation
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Zhejiang Cancer HospitalRecruitingDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
Asan Medical CenterCheolwon SuhRecruitingDiffuse Large B Cell LymphomaKorea, Republic of
-
Innovent Biologics (Suzhou) Co. Ltd.Withdrawn
-
Sun Yat-sen UniversityCompletedLymphoma, Large B-Cell, DiffuseChina
-
Helse FonnaCompletedAutoimmune Hemolytic Anemia | Cold Agglutinin DiseaseFinland, Denmark, Norway
-
Hoag Memorial Hospital PresbyterianCancer Biotherapy Research GroupWithdrawn
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
Ruijin HospitalNot yet recruitingLymphoma, Large B-Cell, DiffuseChina